This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Induction of Labor in Oligohydramnios

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2012 by Meir Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by (Responsible Party):
Meir Medical Center Identifier:
First received: December 25, 2008
Last updated: March 22, 2012
Last verified: March 2012

When oligohydramnion - decreased amniotic fluid, is diagnosed at term pregnancies, the common practice is to induce labor. Whenever the cervix is not ripened, there are several methods to ripen the cervix, two of which are: mechanical, using a double balloon catheter and pharmacological, with prostaglandins. The aim of the study is to compare those two methods of cervical ripening for patients with significant oligohydramnion at term.

The study will be a prospective randomised trial.

Condition Intervention Phase
Cervical Ripening Device: double balloon catheter Drug: prostaglandins E2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Induction of Labor in Oligohydramnios - A Comparison Between Two Modes of Cervical Ripening for Patients With Oligohydramnios at Term

Resource links provided by NLM:

Further study details as provided by Meir Medical Center:

Primary Outcome Measures:
  • Time from ripening to active labor and to delivery, rates of cesarean section, rates of nonreassuring fetal heart rate during induction of labor. [ Time Frame: during induction of labor, delivery and early post partum ]

Secondary Outcome Measures:
  • patients satisfaction [ Time Frame: induction of labor, delivery and early postpartum ]

Estimated Enrollment: 100
Study Start Date: June 2012
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: double balloon catheter
Cervical ripening by double balloon catheter
Device: double balloon catheter
cervical ripening using double balloon catheter
Placebo Comparator: prostaglandins E2
cervical ripening using prostaglandins E2
Drug: prostaglandins E2
prostaglandins E2 - Intravaginal Propess for 24 hours


Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • singleton pregnancy
  • normal pregnancy, well dated, at term
  • un ripened cervix

Exclusion Criteria:

  • previous cesarean section
  • multiple pregnancy
  • intra uterine growth restricted fetus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00815542

Contact: Tal Biron - Shental, MD 972-577-482716

Meir Medial Center Active, not recruiting
Kfar Saba, Israel
Sponsors and Collaborators
Meir Medical Center
Principal Investigator: Tal Biron - Shental, MD Meir Medical Center, Kfar Saba, Israel, Affiliated to Tel Aviv University
  More Information

Responsible Party: Meir Medical Center Identifier: NCT00815542     History of Changes
Other Study ID Numbers: 034-2011-MMC
Study First Received: December 25, 2008
Last Updated: March 22, 2012

Additional relevant MeSH terms:
Pregnancy Complications
Reproductive Control Agents
Physiological Effects of Drugs processed this record on June 23, 2017